MX2021000776A - Usos de composiciones de curcuminoides. - Google Patents
Usos de composiciones de curcuminoides.Info
- Publication number
- MX2021000776A MX2021000776A MX2021000776A MX2021000776A MX2021000776A MX 2021000776 A MX2021000776 A MX 2021000776A MX 2021000776 A MX2021000776 A MX 2021000776A MX 2021000776 A MX2021000776 A MX 2021000776A MX 2021000776 A MX2021000776 A MX 2021000776A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- curcuminoid compositions
- curcuminoid
- methods
- bioaccessibility
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Inorganic Chemistry (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Fodder In General (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
La presente invención se refiere a métodos y usos de composiciones que comprenden curcumina; en particular, métodos y usos con relación a la mejora de la bioaccesibilidad, biodisponibilidad, bioeficacia y/o bioactividad de curcuminoides en mamíferos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1812776.1A GB201812776D0 (en) | 2018-08-06 | 2018-08-06 | New methods and uses |
GBGB1902266.4A GB201902266D0 (en) | 2019-02-19 | 2019-02-19 | New methods and uses |
PCT/EP2019/071055 WO2020030612A1 (en) | 2018-08-06 | 2019-08-05 | Uses of curcuminoid compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021000776A true MX2021000776A (es) | 2021-06-15 |
Family
ID=67770463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021000776A MX2021000776A (es) | 2018-08-06 | 2019-08-05 | Usos de composiciones de curcuminoides. |
Country Status (10)
Country | Link |
---|---|
US (2) | US20220280448A1 (es) |
EP (1) | EP3833337A1 (es) |
JP (1) | JP2021534105A (es) |
KR (1) | KR20210041037A (es) |
CN (1) | CN112566630A (es) |
AU (1) | AU2019320488A1 (es) |
BR (1) | BR112021001403A2 (es) |
CA (1) | CA3108123A1 (es) |
MX (1) | MX2021000776A (es) |
WO (1) | WO2020030612A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113208109B (zh) * | 2021-04-30 | 2023-08-29 | 河南中大恒源生物科技股份有限公司 | 一种高生物利用度水溶姜黄素及其制备方法以及应用 |
CN113383881B (zh) * | 2021-04-30 | 2023-08-29 | 河南中大恒源生物科技股份有限公司 | 一种液体水溶姜黄素及其制备方法以及应用 |
CN115028886B (zh) * | 2022-06-21 | 2023-11-21 | 贺州学院 | 一种用于检测铅离子的双去甲氧基姜黄素显色薄膜、其制备方法和铅离子快速检测方法 |
WO2024041724A1 (en) * | 2022-08-22 | 2024-02-29 | Givaudan Sa | Composition comprising curcuminoids, modified starch and/or acacia gum and saponins for use as a medicament |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5448511B2 (ja) * | 2008-03-31 | 2014-03-19 | 三栄源エフ・エフ・アイ株式会社 | ウコン色素組成物及びその調製方法 |
EP2359702B1 (en) * | 2010-01-22 | 2014-06-04 | Symrise AG | Solubilization agent for solubilizing polyphenols, flavonoids and/or diterpenoid glucosides |
KR20130106441A (ko) * | 2011-01-31 | 2013-09-27 | 와커 헤미 아게 | 지용성 물질을 포함하는 수용액의 제조방법 |
DE102011056111B4 (de) * | 2011-12-06 | 2013-08-14 | Sensient Colors Europe Gmbh | Emulsion |
ES2646214T3 (es) * | 2012-10-16 | 2017-12-12 | DÖHLER GmbH | Emulsión |
WO2014202364A1 (en) * | 2013-06-21 | 2014-12-24 | Firmenich Sa | Preparation of dried particles comprising menthol |
EP3035947A4 (en) * | 2013-08-19 | 2018-09-26 | Aurea Biolabs Private Limited | A novel composition of curcumin with enhanced bioavailability |
US10016363B2 (en) * | 2014-09-18 | 2018-07-10 | Virun, Inc. | Pre-spray emulsions and powders containing non-polar compounds |
WO2017171091A1 (ja) * | 2016-04-01 | 2017-10-05 | 三栄源エフ・エフ・アイ株式会社 | 固体色素の安定化方法 |
EP3516967A4 (en) * | 2016-09-26 | 2020-05-13 | San-Ei Gen F.F.I., INC. | CURRENT COMPOSITION |
WO2018083677A1 (en) * | 2016-11-07 | 2018-05-11 | Akay Flavours & Aromatics Pvt. Ltd. | Green approach in enhancing the bioavailability of oils, fats and other lipophilic bioactives and compositions thereof |
-
2019
- 2019-08-05 CN CN201980052384.2A patent/CN112566630A/zh active Pending
- 2019-08-05 MX MX2021000776A patent/MX2021000776A/es unknown
- 2019-08-05 BR BR112021001403-9A patent/BR112021001403A2/pt unknown
- 2019-08-05 JP JP2021506662A patent/JP2021534105A/ja active Pending
- 2019-08-05 KR KR1020217006618A patent/KR20210041037A/ko unknown
- 2019-08-05 WO PCT/EP2019/071055 patent/WO2020030612A1/en unknown
- 2019-08-05 EP EP19759301.5A patent/EP3833337A1/en active Pending
- 2019-08-05 US US17/266,320 patent/US20220280448A1/en active Pending
- 2019-08-05 CA CA3108123A patent/CA3108123A1/en active Pending
- 2019-08-05 AU AU2019320488A patent/AU2019320488A1/en active Pending
-
2023
- 2023-11-13 US US18/388,981 patent/US20240115519A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20210041037A (ko) | 2021-04-14 |
US20220280448A1 (en) | 2022-09-08 |
EP3833337A1 (en) | 2021-06-16 |
AU2019320488A1 (en) | 2021-02-18 |
BR112021001403A2 (pt) | 2021-04-27 |
WO2020030612A1 (en) | 2020-02-13 |
CN112566630A (zh) | 2021-03-26 |
JP2021534105A (ja) | 2021-12-09 |
US20240115519A1 (en) | 2024-04-11 |
CA3108123A1 (en) | 2020-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021000776A (es) | Usos de composiciones de curcuminoides. | |
PH12020550051A1 (en) | Glp-1 compositions and uses thereof | |
WO2018229236A3 (en) | COMPOSITIONS COMPRISING BACTERIAL STRAINS | |
WO2017095944A8 (en) | Methods and compositions relating to chondrisomes from blood products | |
WO2017106346A3 (en) | Human immunodeficiency virus neutralizing antibodies | |
WO2016170348A3 (en) | Sarna compositions and methods of use | |
MX2017004838A (es) | Composiciones de interleucina-15 y usos de estas. | |
CN107397757A8 (zh) | 润滑剂制剂 | |
WO2019123015A8 (en) | Lysophosphatidylcholine compositions | |
WO2015061798A3 (en) | Compositions and methods comprising yeast organisms and lipid extracts thereof | |
EP3445782A4 (en) | H1.0 DIMETHYLATED K180 PROTEIN COMPOSITIONS AND METHODS | |
WO2017136450A3 (en) | Compounds and methods of treating rna-mediated diseases | |
MX2020001885A (es) | Formulaciones de daptomicina. | |
MX2017012207A (es) | Derivados de aceite natural maleatado a manera de ingredientes agroquimicos inertes. | |
PH12020551716A1 (en) | Anti-ror antibody constructs | |
MX367669B (es) | Compuestos antiproliferativos y sus composiciones farmacéuticas y usos. | |
MX2020006596A (es) | Hidroxiisoxazolinas y derivados de estos. | |
MX2020008125A (es) | Composiciones que comprenden berberina. | |
WO2016020210A8 (en) | Factor viii formulation | |
MX2021000774A (es) | Composiciones de curcuminoides. | |
WO2016100615A3 (en) | Methods and composition for neutralization of influenza | |
EP3539978A4 (en) | NKX3.2 FRAGMENT AND PHARMACEUTICAL COMPOSITION WITH IT AS THE ACTIVE INGREDIENT | |
WO2017123610A3 (en) | Bacteria engineered to detoxify deleterious molecules | |
WO2017075171A3 (en) | Pamam dendrimer based cest imaging agents and uses thereof | |
WO2016056026A3 (en) | Synergistic composition for osteoarthritis |